According to Titan Pharmaceuticals 's latest financial reports the company's total assets are $8.08 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $4.05 M | -49.24% |
2021-12-31 | $7.99 M | -1.15% |
2020-12-31 | $8.08 M | -15.07% |
2019-12-31 | $9.52 M | -32.44% |
2018-12-31 | $14.09 M | 58.28% |
2017-12-31 | $8.9 M | -52.3% |
2016-12-31 | $18.66 M | 40.49% |
2015-12-31 | $13.28 M | -36.28% |
2014-12-31 | $20.85 M | 13.18% |
2013-12-31 | $18.42 M | -25.79% |
2012-12-31 | $24.82 M | 143% |
2011-12-31 | $10.21 M | 115% |
2010-12-31 | $4.75 M | 27.54% |
2009-12-31 | $3.72 M | |
2007-12-31 | $30.84 M | 105.08% |
2006-12-31 | $15.04 M | -23.8% |
2005-12-31 | $19.73 M | -48.9% |
2004-12-31 | $38.62 M | -21.18% |
2003-12-31 | $49 M | -35.45% |
2002-12-31 | $75.92 M | -29.13% |
2001-12-31 | $0.10 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 2,072,098.86% | ๐บ๐ธ USA |
Novartis NVS | $94.33 B | 1,166,533.69% | ๐จ๐ญ Switzerland |
Vanda Pharmaceuticals VNDA | $0.64 B | 7,919.29% | ๐บ๐ธ USA |
Repligen
RGEN | $2.82 B | 34,829.63% | ๐บ๐ธ USA |
MediciNova MNOV | $66.27 M | 719.56% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.46 B | 5,658.43% | ๐บ๐ธ USA |